Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ormeloxifene - Central Drug Research Institute

Next Previous
Drug Profile

Ormeloxifene - Central Drug Research Institute

Alternative Names: Centchroman; Centron; Chhaya; Choice-7; Novex; Novex-DS; Saheli; Sevista; Tatkal-72

Latest Information Update: 26 Apr 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Central Drug Research Institute
  • Developer Hindustan Latex
  • Class Chromans; Contraceptives; Pyrrolidines; Small molecules
  • Mechanism of Action Estrogen receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Metrorrhagia; Pregnancy
  • Phase II Breast cancer

Most Recent Events

  • 26 Apr 2022 Phase II trial is still ongoing for Breast cancer (Metastatic disease, Recurrent, Second-line therapy or greater) in India (PO) (CTRI2018-06-014620)
  • 31 Dec 2006 Early research in Metrorrhagia in India (PO)
  • 16 Jul 2001 A study in volunteers has been added to the adverse events and pharmacokinetics sections

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top